Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5h)-pteridinone
2. Gs-9620
1. Gs-9620
2. 1228585-88-3
3. Gs9620
4. Vesatolimod [inn]
5. 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5h)-one
6. 8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5h)-one
7. Gs 9620
8. Chembl2424780
9. O8m467c50g
10. Mfcd25372045
11. 4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one
12. 6(5h)-pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-((3-(1-pyrrolidinylmethyl)phenyl)methyl)-
13. 4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one
14. Unii-o8m467c50g
15. Vesatolimod (usan/inn)
16. Vesatolimod [usan:inn]
17. Vesatolimod [usan]
18. Vesatolimod [who-dd]
19. Schembl10083191
20. Dtxsid40153741
21. Hms3750i03
22. Amy41043
23. Bcp08305
24. Ex-a2065
25. Bdbm50440284
26. S7221
27. Zinc95616590
28. Akos025290740
29. Ccg-268776
30. Cs-1352
31. Db12687
32. Sb16757
33. Ncgc00390283-01
34. Ncgc00390283-02
35. Ncgc00390283-03
36. Ac-30275
37. As-74316
38. Da-33595
39. Hy-15601
40. Sy028554
41. Ft-0721305
42. D11003
43. Q27285487
44. 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5h)-pteridinone
45. 4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5h)-pteridinone
46. 4-amino-2-butoxy-8-((3-((pyrrolidin-1-yl)methyl)phenyl)methyl)-7,8-dihydropteridin-6(5h)-one
47. 4-amino-2-butoxy-8-({3-[(pyrrolidin-1-yl)methyl]phenyl}methyl)-5,6,7,8-tetrahydropteridin-6-one
48. 9jr
| Molecular Weight | 410.5 g/mol |
|---|---|
| Molecular Formula | C22H30N6O2 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 410.24302422 g/mol |
| Monoisotopic Mass | 410.24302422 g/mol |
| Topological Polar Surface Area | 96.6 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 558 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
56
PharmaCompass offers a list of Vesatolimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vesatolimod manufacturer or Vesatolimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vesatolimod manufacturer or Vesatolimod supplier.
PharmaCompass also assists you with knowing the Vesatolimod API Price utilized in the formulation of products. Vesatolimod API Price is not always fixed or binding as the Vesatolimod Price is obtained through a variety of data sources. The Vesatolimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vesatolimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vesatolimod, including repackagers and relabelers. The FDA regulates Vesatolimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vesatolimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vesatolimod supplier is an individual or a company that provides Vesatolimod active pharmaceutical ingredient (API) or Vesatolimod finished formulations upon request. The Vesatolimod suppliers may include Vesatolimod API manufacturers, exporters, distributors and traders.
Vesatolimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vesatolimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vesatolimod GMP manufacturer or Vesatolimod GMP API supplier for your needs.
A Vesatolimod CoA (Certificate of Analysis) is a formal document that attests to Vesatolimod's compliance with Vesatolimod specifications and serves as a tool for batch-level quality control.
Vesatolimod CoA mostly includes findings from lab analyses of a specific batch. For each Vesatolimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vesatolimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Vesatolimod EP), Vesatolimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vesatolimod USP).
